Elevated expression of Rad18 regulates melanoma cell proliferation

Pigment Cell and Melanoma Research

Volumn 25, Issue 2, 2012, Pages 213-218

  Wong, Ronald P C ^a   Aguissa Touré, Almass Houd ^a   Wani, Aijaz A ^a   Khosravi, Shahram ^a   Martinka, Michal ^a   Martinka, Magdalena ^b   Li, Gang ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Akt; Cell proliferation; Melanoma; Rad18; Tissue microarray

Indexed keywords

CYCLIN D1; PROTEIN KINASE B; RAD18 PROTEIN;

ADULT; ARTICLE; CANCER SURVIVAL; CASE REPORT; CELL PROLIFERATION; DYSPLASTIC NEVUS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; METASTASIS; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; SKIN PROTECTION; SKINFOLD THICKNESS; SUN EXPOSURE; SURVIVAL TIME; TISSUE MICROARRAY; UPREGULATION;

CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-AKT; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84862804582     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2011.00948.x     Document Type: Article

References (24)

1. Chudnovsky, Y., Khavari, P.A., and Adams, A.E. (2005). Melanoma genetics and the development of rational therapeutics. J. Clin. Invest. 115, 813-824.
2. Dai, D.L., Martinka, M., and Li, G. (2005). Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases. J. Clin. Oncol. 23, 1473-1482.
3. Dong, Y.P., Seki, M., Yoshimura, A., Inoue, E., Furukawa, S., Tada, S., and Enomoto, T. (2007). WRN functions in a RAD18-dependent damage avoidance pathway. Biol. Pharm. Bull. 30, 1080-1083.
4. Fresno Vara, J.A., Casado, E., De Castro, J., Cejas, P., Belda-Iniesta, C., and Gonzalez-Baron, M. (2004). PI3K/Akt signalling pathway and cancer. Cancer Treat. Rev. 30, 193-204.
5. Hanahan, D., and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
6. Houghton, A.N., and Polsky, D. (2002). Focus on melanoma. Cancer Cell 2, 275-278.
7. Jansen, J.G., Fousteri, M.I., and De Wind, N. (2007). Send in the clamps: control of DNA translesion synthesis in eukaryotes. Mol. Cell 28, 522-529.
8. Kannouche, P.L., Wing, J., and Lehmann, A.R. (2004). Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol. Cell 14, 491-500.
9. Kanzaki, H., Ouchida, M., Hanafusa, H. et al. (2007). Single nucleotide polymorphism in the RAD18 gene and risk of colorectal cancer in the Japanese population. Oncol. Rep. 18, 1171-1175.
10. Kanzaki, H., Ouchida, M., Hanafusa, H. et al. (2008). The association between RAD18 Arg302Gln polymorphism and the risk of human non-small-cell lung cancer. J. Cancer Res. Clin. Oncol. 134, 211-217.
11. Kunkel, T.A. (2004). DNA replication fidelity. J. Biol. Chem. 279, 16895-16898.
12. Ling, H., Boudsocq, F., Plosky, B.S., Woodgate, R., and Yang, W. (2003). Replication of a cis-syn thymine dimer at atomic resolution. Nature 424, 1083-1087.
13. Madhunapantula, S.V., and Robertson, G.P. (2009). The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma. Pigment Cell Melanoma Res. 22, 400-419.
14. Miyase, S., Tateishi, S., Watanabe, K., Tomita, K., Suzuki, K., Inoue, H., and Yamaizumi, M. (2005). Differential regulation of Rad18 through Rad6-dependent mono- and polyubiquitination. J. Biol. Chem. 280, 515-524.
15. Nakamura, T., Ishikawa, S., Koga, Y., Nagai, Y., Imamura, Y., Ikeda, K., Mori, T., Nomori, H., and Baba, H. (2009). Mutation analysis of Rad18 in human cancer cell lines and non small cell lung cancer tissues. J. Exp. Clin. Cancer Res. 28, 106.
16. Niimi, A., Brown, S., Sabbioneda, S., Kannouche, P.L., Scott, A., Yasui, A., Green, C.M., and Lehmann, A.R. (2008). Regulation of proliferating cell nuclear antigen ubiquitination in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 105, 16125-16130.
17. Omholt, K., Krockel, D., Ringborg, U., and Hansson, J. (2006). Mutations of PIK3CA are rare in cutaneous melanoma. Melanoma Res. 16, 197-200.
18. Putnam, C.D., Hayes, T.K., and Kolodner, R.D. (2010). Post-replication repair suppresses duplication-mediated genome instability. PLoS Genet. 6, e1000933.
19. Smalley, K.S., and Herlyn, M. (2005). Targeting intracellular signaling pathways as a novel strategy in melanoma therapeutics. Ann. N Y Acad. Sci. 1059, 16-25.
20. Tateishi, S., Sakuraba, Y., Masuyama, S., Inoue, H., and Yamaizumi, M. (2000). Dysfunction of human Rad18 results in defective postreplication repair and hypersensitivity to multiple mutagens. Proc. Natl. Acad. Sci. U. S. A. 97, 7927-7932.
21. Trincao, J., Johnson, R.E., Escalante, C.R., Prakash, S., Prakash, L., and Aggarwal, A.K. (2001). Structure of the catalytic core of S. cerevisiae DNA polymerase eta: implications for translesion DNA synthesis. Mol. Cell 8, 417-426.
22. Wang, Y., Woodgate, R., Mcmanus, T.P., Mead, S., Mccormick, J.J., and Maher, V.M. (2007). Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations. Cancer Res. 67, 3018-3026.
23. Watanabe, K., Tateishi, S., Kawasuji, M., Tsurimoto, T., Inoue, H., and Yamaizumi, M. (2004). Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J. 23, 3886-3896.
24. Woodgett, J.R. (2005). Recent advances in the protein kinase B signaling pathway. Curr. Opin. Cell Biol. 17, 150-157.